赛托生物(300583.SZ)：拟变更部分募集资金投资项目

Group 1 - The company, Saito Bio (300583.SZ), announced adjustments to its fundraising investment plans to enhance the efficiency of fund utilization, with a total investment amount revised to 229.3766 million yuan and the amount of raised funds adjusted to 130.2922 million yuan [1] - The company plans to redirect part of the raised funds to a new project, "Biological Synthesis Technology R&D and Industrialization Project," which will be implemented by its wholly-owned subsidiary, Shandong Jinweiduo Pharmaceutical Co., Ltd. (referred to as "Jinweiduo") [1] - The new project involves an overall investment of 237.1312 million yuan, with an intended raised fund input of 124.3688 million yuan (including interest of 2.7386 million yuan) [1] Group 2 - The company intends to increase its capital in Jinweiduo by 100 million yuan using the raised funds and provide a loan of 24.3688 million yuan to Jinweiduo, with the remaining funds to be sourced by Jinweiduo itself [1]